Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites

被引：11
|
作者：
Kawai, Makoto
Sakurada, Isao
Morita, Asato
Iwamuro, Yuko
Ando, Kazuo
Omura, Hirofumi
Sakakibara, Sachiko
Masuda, Tsutomu
Koike, Hiroki
Honma, Teruki
Hattori, Kazunari
Takashima, Tadayuki
Mizuno, Kunihiko
Mizutani, Mayumi
Kawamura, Mitsuhiro
机构：
[1] Pfizer Global Res & Dev, Nagoya Labs, Discovery Chem, Aichi 4702393, Japan
[2] Pfizer Global Res & Dev, Nagoya Labs, Pharmacokinet Dynam & Metab, Aichi 4702393, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 20期
关键词：
reactive metabolite; bioactivation; NR2B; NMDA; metabolic stability;
D O I：
10.1016/j.bmcl.2007.08.033
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A novel potent NMDA-NR2B selective antagonist (5b) without the reactive metabolites formation issue was identified. Through this study, a close correlation between reactive metabolites formation and calculated HOMO energies of parent compounds was found. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5537 / 5542
页数：6
相关论文
共 50 条
  • [21] Design of novel NR2B-selective NMDA negative allosteric modulators for treatment- resistant depression
    Thompson, Lorin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [22] Synthesis and structure-activity relationship of novel VLA-4 antagonists.
    Ikegami, S
    Hoshina, Y
    Okuyama, A
    Fukui, H
    Inoguchi, K
    Fujimoto, K
    Maruyama, T
    Harada, T
    Nakamura, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U35 - U35
  • [23] Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists
    Zheng, GZ
    Bhatia, P
    Daanen, J
    Kolasa, T
    Patel, M
    Latshaw, S
    El Kouhen, OF
    Chang, RJ
    Uchic, ME
    Miller, L
    Nakane, M
    Lehto, SG
    Honore, MP
    Moreland, RB
    Brioni, JD
    Stewart, AO
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) : 7374 - 7388
  • [24] Fungal Metabolites Antagonists towards Plant Pests and Human Pathogens: Structure-Activity Relationship Studies
    Masi, Marco
    Nocera, Paola
    Reveglia, Pierluigi
    Cimmino, Alessio
    Evidente, Antonio
    MOLECULES, 2018, 23 (04):
  • [25] Structure-activity relationship study of novel necroptosis inhibitors
    Teng, X
    Degterev, A
    Jagtap, P
    Xing, XC
    Choi, S
    Denu, R
    Yuan, JY
    Cuny, GD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (22) : 5039 - 5044
  • [26] MEDI 72-Design, synthesis and structure-activity relationship of novel CCR2 antagonists
    Kothandaraman, Shankaran
    Donnely, Karla L.
    Jiao, Richard X.
    Butora, Gabor
    Pasternak, Alexander
    Morriello, Gregori J.
    Goble, Steve
    Zhou, Changyou
    Yang, Lihu
    Mills, Sander G.
    MacCoss, Malcolm
    Ayala, Julia M.
    Vicario, Pasquale P.
    Cascieri, Margaret A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [27] Structure-activity study of novel tricyclic benzazepine arginine vasopressin antagonists
    Sum, FW
    Dusza, J
    Delos Santos, E
    Grosu, G
    Reich, M
    Du, XM
    Albright, JD
    Chan, P
    Coupet, J
    Ru, X
    Mazandarani, H
    Saunders, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (13) : 2195 - 2198
  • [28] Structure-activity study of kinin B1 receptor antagonists
    Regoli, D
    Neugebauer, W
    Gobeil, F
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R334 - R334
  • [29] Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles
    Chu, L
    Hutchins, JE
    Weber, AE
    Lo, JL
    Yang, YT
    Cheng, K
    Smith, RG
    Fisher, MH
    Wyvratt, MJ
    Goulet, MT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (04) : 509 - 513
  • [30] Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists
    Chazot, PL
    Lawrence, S
    Thompson, CL
    NEUROPHARMACOLOGY, 2002, 42 (03) : 319 - 324
12345